Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

NCT02233049 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Erlotinib
DRUG: Everolimus
DRUG: Dasatinib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]